GLOBAL MENOPAUSE TREATMENT MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024-2031)

Global Menopause Treatment Market, By Treatment Type (Hormone Therapy, Non-hormonal Therapy, Others), By Route of Administration (Oral, Topical, Parenteral, Vaginal, Others), By Form (Tablets, Creams, Patches , Pessaries, Injections, Others), By Indication (Perimenopause, Menopause, Postmenopause), By Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies, Specialty Stores, Others), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East and Africa).

Published In : Feb 2024
Code : CMI6676
Pages :180
Formats :
Excel and PDF
Industry : Pharmaceutical

Global Menopause Treatment Market Size and Trends

The global menopause treatment market was valued US$ 15.33 Bn in 2023 and is expected to reach US$ 24.33 Bn by 2031 growing at a compound annual growth rate (CAGR) of 5.9% from 2024 to 2031.

Global Menopause Treatment Market – Trends

Combination therapy practices: Combination therapy practices have significantly influenced the global menopause treatment market in recent years. With the rise in awareness about safer and more effective treatment options beyond hormone replacement therapy alone, combination therapies are being increasingly adopted by patients and doctors. Combination therapies involve the use of two or more medical approaches together. For menopause, this often includes combining low-dose HRT with other supplements or medications. For example, pairing a selective estrogen receptor modulator like ospemifene with a low-dose estrogen preparation. Or combining an SSRI antidepressant like paroxetine with a low-dose local estrogen. The goal is to attain relief from multiple symptoms like hot flashes, mood issues, sleep problems, and vaginal dryness using synergistic therapies with lower individual doses. This multi-targeted approach is effective at improving quality of life and also lowers health risks associated with high HRT doses.